Prestige Consumer Healthcare (PBH) Change in Inventory (2010 - 2025)
Prestige Consumer Healthcare's (PBH) quarterly Change in Inventory came in at -$3.2 million in Q4 2025, down 3.95% year-on-year from -$3.3 million in Q4 2024, and down 154.97% quarter-over-quarter from $5.8 million in Q3 2025.
Prestige Consumer Healthcare (PBH) Change in Inventory (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Change in Inventory history runs 16 years deep, the most recent figure standing at -$3.2 million for Q4 2025.
- On a quarterly basis, Change in Inventory fell 3.95% year-over-year to -$3.2 million in Q4 2025; TTM through Dec 2025 was $3.0 million, a 9.58% increase from a year earlier, with the FY2025 full-year figure at $9.3 million, up 138.11% from the prior year.
- Change in Inventory retreated to -$3.2 million in Q4 2025 per PBH's latest filing, from $5.8 million in the prior quarter.
- Across five years, Change in Inventory topped out at $16.8 million in Q4 2022 and bottomed at -$13.6 million in Q4 2023.
- The 5-year median for Change in Inventory is $875500.0 (2021), against an average of $1.6 million.
- Across the five-year window, Change in Inventory slumped 18300.0% in 2021 and surged 1103.41% in 2022, its largest moves.
- Year by year, Change in Inventory stood at -$1.7 million in 2021, then jumped by 1103.41% to $16.8 million in 2022, then slumped by 180.87% to -$13.6 million in 2023, then soared by 77.25% to -$3.1 million in 2024, then declined by 3.95% to -$3.2 million in 2025.
- Per Business Quant, the three latest PBH Change in Inventory figures stand at -$3.2 million (Q4 2025), $5.8 million (Q3 2025), and $4.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.34 Bn | 2.28 Bn | 157.37 Mn | -3.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.21 Mn |
| Dec 31, 2025 | -3.21 Mn |
| Sep 30, 2025 | 5.84 Mn |
| Sep 30, 2025 | 5.84 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Jun 30, 2025 | 4.44 Mn |
| Mar 31, 2025 | -4.07 Mn |
| Mar 31, 2025 | -4.07 Mn |
| Dec 31, 2024 | -3.09 Mn |
| Dec 31, 2024 | -3.09 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 13.05 Mn |
| Jun 30, 2024 | 13.05 Mn |
| Mar 31, 2024 | -10.65 Mn |
| Mar 31, 2024 | -10.65 Mn |
| Dec 31, 2023 | -13.57 Mn |
| Dec 31, 2023 | -13.57 Mn |
| Sep 30, 2023 | -7.93 Mn |
| Sep 30, 2023 | -7.93 Mn |